Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

Purpose [F-18]flortaucipir binds to paired helical filament tau and accurately identifies tau in Alzheimer's disease (AD). However, off-target binding interferes with the quantification of [F-18]flortaucipir in several brain regions. Recently, other tau PET tracers have been developed. Here, we compare [F-18]flortaucipir with the novel tau tracer [F-18]RO948 head-to-head in vivo. Methods We included 18 participants with AD, three with amyloid-beta-positive amnestic mild cognitive impairment, and four healthy controls. All underwent [F-18]flortaucipir (80-100 min) and [F-18]RO948 (70-90) PET scans within approximately 1 month. Four study participants underwent 0-100-min dynamic scanning. Standardized uptake value ratios (SUVRs) were created using an inferior cerebellar reference region. Results Neocortical tracer retention was highly comparable using both SUVR and distribution volume ratio-1 values obtained from dynamic scans. However, [F-18]RO948 retention was significantly higher in the entorhinal cortex and lower in the basal ganglia, thalamus, and choroid plexus compared with [F-18]flortaucipir. Increased off-target binding was observed with age for both tracers. Several cases exhibited strong [F-18]RO948 retention in the skull/meninges. This extra-cerebral signal, however, did not affect diagnostic accuracy and remained relatively unchanged when re-examining a subsample after 1 year. Kinetic modeling showed an increase in [F-18]flortaucipir SUVR over the scanning interval, compared with a plateau for [F-18]RO948. Conclusion [F-18]RO948 and [F-18]flortaucipir bound comparably in neocortical regions, but [F-18]RO948 showed higher retention in the medial temporal lobe and lower intracerebral off-target binding. Time-dependent bias of SUVR estimates may prove less of a factor with [F-18]RO948, compared with previous tau ligands.